At a glance
ClinicalIndex Comparison RecordN/AActive· 12,000 target
Drug / intervention
LDCTother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Low Dose Computed Tomography Screening Study in Non-smokers with Risk Factors for Lung Cancer in Taiwan
In Brief
An observational study evaluating LDCT for Lung Cancer. Active but no longer recruiting, targeting 12,000 participants across 17 sites.
Detailed Summary
This study utilizes the low dose computed tomography(LDCT) to detect the occurrence of early lung cancer among non-smokers in Taiwan. Subjects who have family history of lung cancer or have high risk exposures to lung cancer will be recruited to participate LDCT screening and followed up for their possible occurrence of lung cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLung Cancer
CountriesTaiwan
CollaboratorsTaiwan Lung Cancer Society, National Taiwan University Hospital, Taipei Veterans General Hospital, Taiwan, Tri-Service General Hospital, Chang Gung Memorial Hospital, Taichung Veterans General Hospital, Chung Shan Medical University, Kaohsiung Veterans General Hospital., Kaohsiung Medical University Chung-Ho Memorial Hospital, China Medical University Hospital, National Health Research Institutes, Taiwan, Ministry of Health and Welfare, Taiwan
Timeline
N/AActive
20152016201720182019202020212022202320242025202620272028
Enrollment StartOct 2014
First PostedNov 2015
TodayJul 2026
Primary CompletionJul 2027
Study CompletionJul 2028
First PostedNov 23, 2015
Enrollment StartOct 1, 2014
Primary CompletionJul 1, 2027
Study CompletionJul 1, 2028
TodayJul 2, 2026
Enrollment to primary: 12.8 yearsPosted 10.6 years agoPrimary completion in 12 months
Interventions
LDCTother
LDCT at enrollment, annually for two years and biennially for 6 years if no lung cancer is detected